Hot Pursuit     07-Jun-24
Biocon Ltd spurts 1.22%, gains for third straight session
Biocon Ltd is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The stock is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.78% on the day, quoting at 23226.9. The Sensex is at 76478.93, up 1.87%. Biocon Ltd has added around 9.71% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 3.55% in last one month and is currently quoting at 19232.1, up 1.5% on the day. The volume in the stock stood at 107.76 lakh shares today, compared to the daily average of 101.91 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 337.3, up 0.9% on the day. Biocon Ltd is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

The PE of the stock is 369.61 based on TTM earnings ending March 24.

Previous News
  Biocon Ltd spurts 1.95%, up for third straight session
 ( Hot Pursuit - 12-Nov-25   13:05 )
  Biocon reports consolidated net profit of Rs 84.50 crore in the September 2025 quarter
 ( Results - Announcements 12-Nov-25   07:46 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 06-Nov-25   13:05 )
  Biocon's biologics arm gets Health Canada approval for monoclonal antibody drug Yesintek
 ( Hot Pursuit - 23-Oct-25   12:58 )
  Biocon Biologics expands its strategic collaboration with Civica
 ( Corporate News - 16-Oct-25   16:28 )
  Biocon inaugurates first US manufacturing facility in New Jersey
 ( Hot Pursuit - 13-Oct-25   08:16 )
  Biocon's subsidiary get US FDA approval for diarrhea medication Rifaximin
 ( Hot Pursuit - 07-Oct-25   09:58 )
  Biocon schedules board meeting
 ( Corporate News - 07-Oct-25   09:43 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 01-Oct-25   13:05 )
  Biocon Biologics inks settlement and license agreement with Amgen Inc.
 ( Corporate News - 01-Oct-25   10:33 )
  Biocon gains on U.S. entry for denosumab biosimilars
 ( Hot Pursuit - 01-Oct-25   10:13 )
Other Stories
  Eicher Motors Q2 PAT climbs 24% YoY to Rs 1,369 cr
  13-Nov-25   18:26
  Hariom Pipe Industries tumbles after Q2 PAT fall 34% YoY to Rs 10 cr
  13-Nov-25   15:18
  Infibeam Avenues spurts after Q2 PAT climbs 51% YoY to Rs 66 cr
  13-Nov-25   15:15
  K&R Rail Engineering slumps after dismal Q2 performance
  13-Nov-25   15:09
  Marine Electricals rises as new orders boost order book
  13-Nov-25   15:03
  Cohance Lifesciences Ltd leads losers in 'A' group
  13-Nov-25   15:00
  Eco Recycling Ltd leads losers in 'B' group
  13-Nov-25   14:45
  Valor Estate spurts as Advent Hotels makes a strong debut
  13-Nov-25   14:31
  Volumes jump at Ramkrishna Forgings Ltd counter
  13-Nov-25   14:30
  Axiscades Tech hits the roof after Q2 PAT spurts 89% YoY to Rs 23 cr
  13-Nov-25   14:17
Back Top